Caren Deardorf

Director/Board Member at CRINETICS PHARMACEUTICALS, INC.

Net worth: 831 660 $ as of 2026-06-29

61 year

34 connections

Health Technology

Commercial Services

Consumer Services

Profile

Caren Deardorf is currently Director at Pan Mass Challenge, Independent Director at Crinetics Pharmaceuticals, Inc. since 2022, and Secretary & Director at Pan Massachusetts Challenge, Inc. Former roles include Director at Can Do Multiple Sclerosis, Independent Director at Neurosense Therapeutics Ltd. from 2021 to 2024, Chief Commercial & Strategy Officer at Editas Medicine, Inc. from 2023 to 2025, Chief Commercial Officer at Magenta Therapeutics, Inc. from 2021 to 2023, Chief Commercial Officer at Ohana Biosciences, Inc. from 2019 to 2021, and VP-Product Development & Commercialization at Biogen, Inc. from 2017 to 2019.
Education includes undergraduate studies at Tufts University and an MBA from F.W.
Olin Graduate School of Business.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
CRINETICS PHARMACEUTICALS INC 0.02%	2026-06-17	22,225 ( 0.02% )	831 660 $	2026-06-29

Caren Deardorf active positions

Companies	Position	Start
CRINETICS PHARMACEUTICALS, INC.	Director/Board Member	2022-03-10
Pan Mass Challenge Pan Mass Challenge Miscellaneous Commercial ServicesCommercial Services Provides fund raises money for life-saving cancer research and treatment	Director/Board Member	-
Pan Massachusetts Challenge, Inc. Pan Massachusetts Challenge, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in raising funds for cancer research and treatment	Director/Board Member	-

All active positions of Caren Deardorf

Former positions of Caren Deardorf

Companies	Position	End
EDITAS MEDICINE, INC.	Corporate Officer/Principal	2025-03-31
NEUROSENSE THERAPEUTICS LTD.	Director/Board Member	2024-06-26
MAGENTA THERAPEUTICS	Corporate Officer/Principal	2023-02-06
Ohana Biosciences, Inc. Ohana Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Operates early stage biotechnology company	Corporate Officer/Principal	2021-04-30
BIOGEN INC.	Corporate Officer/Principal	2018-12-31

See the detail of Caren Deardorf's experience

Training of Caren Deardorf

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Caren Deardorf's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	11
Biogen, Inc. Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases	Health Technology
Tufts University Tufts University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Can Do Multiple Sclerosis Can Do Multiple Sclerosis Miscellaneous Commercial ServicesCommercial Services Provides lifestyle empowerment programs	Commercial Services
Pan Mass Challenge Pan Mass Challenge Miscellaneous Commercial ServicesCommercial Services Provides fund raises money for life-saving cancer research and treatment	Commercial Services
Editas Medicine, Inc. Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines	Health Technology
F.W. Olin Graduate School of Business F.W. Olin Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Crinetics Pharmaceuticals, Inc. Crinetics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets therapeutics for endocrine-related diseases	Health Technology
Magenta Therapeutics, Inc. Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines	Health Technology
Ohana Biosciences, Inc. Ohana Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Operates early stage biotechnology company	Commercial Services
Neurosense Therapeutics Ltd. Neurosense Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage drug development company	Health Technology
Pan Massachusetts Challenge, Inc. Pan Massachusetts Challenge, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in raising funds for cancer research and treatment	Commercial Services